Fenwal recalls blood component infusion set

Lake Zurich, Ill.-based blood technology company Fenwal initiated a recall of their Blood Component Infusion Set on Oct. 4, due to incorrect labeling.

According to an FDA release, the infusion set is labeled as an 80 Micron filter, when the actual filter size is a standard blood filter of 170 to 260 microns in size. The developer urges customers to immediately discontinue use of the product and return it to Fenwal.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.